These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19149662)

  • 1. alpha-halogenoacrylic derivatives of antitumor agents.
    Romagnoli R; Baraldi PG; Cruz-Lopez O; Lopez-Cara C; Preti D
    Mini Rev Med Chem; 2009 Jan; 9(1):81-94. PubMed ID: 19149662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic alpha-halogenoacrylic derivatives of distamycin A and congeners.
    Beria I; Baraldi PG; Cozzi P; Caldarelli M; Geroni C; Marchini S; Mongelli N; Romagnoli R
    J Med Chem; 2004 May; 47(10):2611-23. PubMed ID: 15115402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic halogenoacrylic derivatives of distamycin A.
    Cozzi P; Beria I; Caldarelli M; Capolongo L; Geroni C; Mongelli N
    Bioorg Med Chem Lett; 2000 Jun; 10(11):1269-72. PubMed ID: 10866397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brostallicin (PNU-166196), a new minor groove DNA binder: preclinical and clinical activity.
    Lorusso D; Mainenti S; Pietragalla A; Ferrandina G; Foco G; Masciullo V; Scambia G
    Expert Opin Investig Drugs; 2009 Dec; 18(12):1939-46. PubMed ID: 19938904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid molecules between distamycin A and active moieties of antitumor agents.
    Baraldi PG; Preti D; Fruttarolo F; Tabrizi MA; Romagnoli R
    Bioorg Med Chem; 2007 Jan; 15(1):17-35. PubMed ID: 17081759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The discovery of a new potential anticancer drug: a case history.
    Cozzi P
    Farmaco; 2003 Mar; 58(3):213-20. PubMed ID: 12620417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: an European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study.
    Gelderblom H; Blay JY; Seddon BM; Leahy M; Ray-Coquard I; Sleijfer S; Kerst JM; Rutkowski P; Bauer S; Ouali M; Marreaud S; van der Straaten RJ; Guchelaar HJ; Weitman SD; Hogendoorn PC; Hohenberger P
    Eur J Cancer; 2014 Jan; 50(2):388-96. PubMed ID: 24215845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA sequence-recognizing properties of minor groove alkylating agents. Effects of the replacement of N-methylpyrrole by an N-methylimidazole on tallimustine and its own homologue.
    Baraldi PG; Romagnoli R; Spalluto G; Cozzi P; Mongelli N; Bianchi N; Gambari R
    Arzneimittelforschung; 2000 Mar; 50(3):309-15. PubMed ID: 10758785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discorhabdins and pyrroloiminoquinone-related alkaloids.
    Hu JF; Fan H; Xiong J; Wu SB
    Chem Rev; 2011 Sep; 111(9):5465-91. PubMed ID: 21688850
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytotoxic alpha-bromoacrylic derivatives of distamycin analogues modified at the amidino moiety.
    Cozzi P; Beria I; Caldarelli M; Geroni C; Mongelli N; Pennella G
    Bioorg Med Chem Lett; 2000 Jun; 10(11):1273-6. PubMed ID: 10866398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, DNA binding, and biological evaluation of water-soluble hybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders.
    Baraldi PG; Balboni G; Pavani MG; Spalluto G; Tabrizi MA; Clercq ED; Balzarini J; Bando T; Sugiyama H; Romagnoli R
    J Med Chem; 2001 Aug; 44(16):2536-43. PubMed ID: 11472207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on duocarmycin SA and its derivatives.
    Nagamura S; Asai A; Kobayashi E; Gomi K; Saito H
    Bioorg Med Chem; 1997 Mar; 5(3):623-30. PubMed ID: 9113339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzoyl and cinnamoyl nitrogen mustard derivatives of benzoheterocyclic analogues of the tallimustine: synthesis and antitumour activity.
    Baraldi PG; Romagnoli R; Giovanna Pavani M; del Carmen Nunez M; Bingham JP; Hartley JA
    Bioorg Med Chem; 2002 May; 10(5):1611-8. PubMed ID: 11886822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity and distribution of pyrroloiminoquinones in the sponge genus Zyzzya.
    Dijoux MG; Schnabel PC; Hallock YF; Boswell JL; Johnson TR; Wilson JA; Ireland CM; van Soest R; Boyd MR; Barrows LR; Cardellina JH
    Bioorg Med Chem; 2005 Nov; 13(21):6035-44. PubMed ID: 16009557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel cyclopropapyrroloindole(CPI) bisalkylators bearing 3,3'-(1,4-phenylene)diacryloyl group as a linker.
    Fukuda Y; Seto S; Furuta H; Ebisu H; Oomori Y; Terashima S
    Bioorg Med Chem Lett; 1998 Aug; 8(15):2003-4. PubMed ID: 9873475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological activity of alpha-bromoacryloyl lexitropsin conjugates.
    Romagnoli R; Baraldi PG; Iaconinoto MA; Carrion MD; Tabrizi MA; Gambari R; Borgatti M; Heilmann J
    Eur J Med Chem; 2005 Nov; 40(11):1123-8. PubMed ID: 16006014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic alpha-bromoacrylic derivatives of low molecular weight.
    Beria I; Caldarelli M; Geroni C; Mongelli N; Reinach B; Vignati L; Cozzi P
    Bioorg Med Chem Lett; 2002 Jun; 12(11):1467-71. PubMed ID: 12031321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient guanine alkylation through cooperative heterodimeric formation of duocarmycin A and distamycin A.
    Isomura M; Sugiyama H; Saito I
    Nucleic Acids Symp Ser; 1995; (34):47-8. PubMed ID: 8841545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of base excision repair in the repair of DNA adducts formed by a series of nitrogen mustard-containing analogues of distamycin of increasing binding site size.
    Brooks N; McHugh PJ; Lee M; Hartley JA
    Anticancer Drug Des; 1999 Feb; 14(1):11-8. PubMed ID: 10363024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I and pharmacokinetic study of brostallicin (PNU-166196), a new DNA minor-groove binder, administered intravenously every 3 weeks to adult patients with metastatic cancer.
    Ten Tije AJ; Verweij J; Sparreboom A; Van Der Gaast A; Fowst C; Fiorentini F; Tursi J; Antonellini A; Mantel M; Hartman CM; Stoter G; Planting AS; De Jonge MJ
    Clin Cancer Res; 2003 Aug; 9(8):2957-64. PubMed ID: 12912942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.